Skip to searchSkip to main content
Uniprism Market Research

HEALTHCARE

Global Hybrid Imaging Market - Industry Trends and Forecast to 2032

Request Free Sample

​REPORT OVERVIEW

Global Hybrid Imaging Market, By Technology (X-ray Imaging Systems, X-ray Digital Imaging Systems, X-ray Analog Imaging Systems), Type (PET/CT systems, SPET/CT systems, PET/MR systems, OCT/Fundus Imaging System, Others), SPECT Market (Standalone SPECT System, Hybrid SPECT System), Application (Oncology, Ophthalmology, Cardiology, Brain & Neurology, Other Applications), End Use (Hospitals, Diagnostic Imaging Centers, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.

Market Insights
The global hybrid imaging market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.

Hybrid imaging combines two or more imaging modalities to provide a single set of images that contain more diagnostic information. This method combines the functional or molecular data from nuclear medicine techniques like PET (Positron Emission Tomography) or SPECT (Single Photon Emission Computed Tomography) with the anatomical detail provided by traditional imaging methods like CT (Computed Tomography) or MRI (Magnetic Resonance Imaging). The hybrid imaging market includes the development, manufacture, and sale of hybrid imaging systems such as PET-CT, PET-MRI, and SPECT-CT. It covers a range of medical specialties where accurate diagnosis and treatment planning are essential, such as neurology, cardiology, and oncology. The market also comprises supporting services, software, and consumables to complement this advanced diagnostic equipment.

The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
  • Increasing significance of combination analysis of anatomic and molecular data
  • High prevalence of chronic diseases
RESTRAINTS
  • High cost of hybrid imaging systems.
  • Limited reimbursement policies in some regions.
OPPORTUNITIES
  • Increasing occurrences of chronic diseases, with cancer
  • Governments of various countries are taking favorable initiatives
CHALLENGES
  • Integration challenges with existing healthcare IT systems.
  • Data privacy and security concerns.

​SEGMENTATION

  • Technology
    •  X-ray Imaging Systems
    •  X-ray Digital Imaging Systems
      • Computed Radiography
      • Direct Radiography
    •  X-ray Analog Imaging Systems
      • Computed Tomography (CT) Scanners
      • High-slice CT Scanners
      • Mid-slice CT Scanners
      • Low-slice CT Scanners
      • Ultrasound Systems
      • 2D Imaging
      • 3D and 4D Imaging
      • Doppler Imaging
      • Magnetic Resonance Imaging (MRI) Systems
      • High- and Very-high-field MRI Systems
      • Low-to-mid-field MRI Systems
      • Ultra-high-field MRI Systems
      • Nuclear Imaging Systems [Single-photon Emission Computed Tomography (SPECT) and Photon Emission Tomography (PET) Systems]
  • Type
    • PET/CT systems
    • SPET/CT systems
    • PET/MR systems
    • OCT/Fundus Imaging System
    • Others
  • SPECT Market
    • Standalone SPECT System
    • Hybrid SPECT System
  • Application
    • Oncology
    • Ophthalmology
    • Cardiology
    • Brain & Neurology
    • Other Applications
  • End Use
    • Hospitals
    • Diagnostic Imaging Centers
    • Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • The Netherlands
    • Belgium
    • Turkey
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Singapore
    • Malaysia
    • Australia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • Kingdom of Saudi Arabia
    • South Africa
    • U.A.E.
    • Egypt
    • Rest of Middle East and Africa

​KEY MARKET PLAYERS

  • GE HealthCare
  • Siemens Healthcare
  • Koninklijke Philips N.V.
  • CANON MEDICAL SYSTEMS CORPORATION
  • Shanghai United Imaging Healthcare Co., LTD
  • TTG IMAGING SOLUTIONS (Digirad)
  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Heidelberg Engineering
  • NIDEK

​Table OF CONTENTS

  • SECTION 1 - INTRODUCTION
  • 1.1 Taxonomy
  • 1.2 Market Overview
  • 1.3 Currency and Limitations
  •   1.3.1 Currency
  •   1.3.2 Limitations
  • 1.4 Key Competitors

  • SECTION 2 - RESEARCH METHODOLOGY
  • 2.1 Research Approach
  • 2.2 Data Collection and Validation
  •   2.2.1 Secondary Research
  •   2.2.2 Primary Research
  • 2.3 Market Assessment
  •   2.3.1 Market Size Estimation
  •   2.3.2 Bottom-up Approach
  •   2.3.3 Top-down Approach
  •   2.3.4 Growth Forecast
  • 2.4 Market Study Assumptions
  • 2.5 Data Sources

  • SECTION 3 - EXECUTIVE SUMMARY
  • 3.1 Global Hybrid Imaging Market, by Technology
  • 3.2 Global Hybrid Imaging Market, by Type
  • 3.3 Global Hybrid Imaging Market, by SPECT Market
  • 3.4 Global Hybrid Imaging Market, by Application
  • 3.5 Global Hybrid Imaging Market, by End Use
  • 3.6 Global Hybrid Imaging Market, by Geography
  • 3.7 Market Position Grid

  • SECTION 4 - PREMIUM INSIGHTS
  • 4.1 Regulatory Framework
  •   4.1.1 Standards
  •   4.1.2 Regulatory Landscape
  • 4.2 Value Chain Analysis
  • 4.3 Supply Chain Analysis
  • 4.4 COVID-19 Impact
  • 4.5 Russia-Ukraine War Impact
  • 4.6 PORTER's Five Force Analysis
  • 4.7 PESTLE Analysis
  • 4.8 SWOT Analysis
  • 4.9 Go to Market Strategy
  • 4.10 Opportunity Orbit
  • 4.11 Multivariate Modelling
  • 4.12 Pricing Analysis

  • SECTION 5 - MARKET DYNAMICS
  • 5.1 Trends
  •   5.1.1 Increasing adoption of hybrid imaging systems in diagnostics and research.
  •   5.1.2 Growing integration of advanced technologies like AI and machine learning.
  •   5.1.3 Trend 3
  • 5.2 Drivers
  •   5.2.1 Increasing significance of combination analysis of anatomic and molecular data
  •   5.2.2 High prevalence of chronic diseases
  •   5.2.3 Driver 3
  •   5.2.4 Driver 4
  • 5.3 Restraints
  •   5.3.1 High cost of hybrid imaging systems.
  •   5.3.2 Limited reimbursement policies in some regions.
  •   5.3.3 Restraint 3
  • 5.4 Opportunities
  •   5.4.1 Increasing occurrences of chronic diseases, with cancer
  •   5.4.2 Governments of various countries are taking favorable initiatives
  •   5.4.3 Opportunity 3
  •   5.4.4 Opportunity 4
  • 5.5 Challenges
  •   5.5.1 Integration challenges with existing healthcare IT systems.
  •   5.5.2 Data privacy and security concerns.
  •   5.5.3 Challenge 3

  • SECTION 6 - GLOBAL HYBRID IMAGING MARKET, BY TECHNOLOGY
  • 6.1 Technology Summary
  • 6.2 Market Attractive Index
  • 6.3 Global Hybrid Imaging Market, by Technology (2019-2032)

  • SECTION 7 - GLOBAL HYBRID IMAGING MARKET, BY TYPE
  • 7.1 Type Summary
  • 7.2 Market Attractive Index
  • 7.3 Global Hybrid Imaging Market, by Type (2019-2032)

  • SECTION 8 - GLOBAL HYBRID IMAGING MARKET, BY SPECT MARKET
  • 8.1 SPECT Market Summary
  • 8.2 Market Attractive Index
  • 8.3 Global Hybrid Imaging Market, by SPECT Market (2019-2032)

  • SECTION 9 - GLOBAL HYBRID IMAGING MARKET, BY APPLICATION
  • 9.1 Application Summary
  • 9.2 Market Attractive Index
  • 9.3 Global Hybrid Imaging Market, by Application (2019-2032)

  • SECTION 10 - GLOBAL HYBRID IMAGING MARKET, BY END USE
  • 10.1 End Use Summary
  • 10.2 Market Attractive Index
  • 10.3 Global Hybrid Imaging Market, by End Use (2019-2032)

  • SECTION 11 - GLOBAL HYBRID IMAGING MARKET, BY GEOGRAPHY
  • 11.1 Regional Summary
  • 11.2 Market Attractive Index
  • 11.3 Global Hybrid Imaging Market, by Geography (2019-2032)

  • SECTION 12 - NORTH AMERICA HYBRID IMAGING MARKET
  • 12.1 North America Summary
  • 12.2 Market Attractive Index
  • 12.3 North America Hybrid Imaging Market, by Technology (2019-2032)
  • 12.4 North America Hybrid Imaging Market, by Type (2019-2032)
  • 12.5 North America Hybrid Imaging Market, by SPECT Market (2019-2032)
  • 12.6 North America Hybrid Imaging Market, by Application (2019-2032)
  • 12.7 North America Hybrid Imaging Market, by End Use (2019-2032)
  • 12.8 North America Hybrid Imaging Market, by Country (2019-2032)
  •   12.8.1 U.S.
  •   12.8.2 Canada
  •   12.8.3 Mexico
  •   12.8.4 Rest of North America

  • SECTION 13 - EUROPE HYBRID IMAGING MARKET
  • 13.1 Europe Summary
  • 13.2 Market Attractive Index
  • 13.3 Europe Hybrid Imaging Market, by Technology (2019-2032)
  • 13.4 Europe Hybrid Imaging Market, by Type (2019-2032)
  • 13.5 Europe Hybrid Imaging Market, by SPECT Market (2019-2032)
  • 13.6 Europe Hybrid Imaging Market, by Application (2019-2032)
  • 13.7 Europe Hybrid Imaging Market, by End Use (2019-2032)
  • 13.8 Europe Hybrid Imaging Market, by Country (2019-2032)
  •   13.8.1 Germany
  •   13.8.2 U.K.
  •   13.8.3 France
  •   13.8.4 Italy
  •   13.8.5 Spain
  •   13.8.6 Russia
  •   13.8.7 The Netherlands
  •   13.8.8 Belgium
  •   13.8.9 Turkey
  •   13.8.10 Rest of Europe

  • SECTION 14 - ASIA-PACIFIC HYBRID IMAGING MARKET
  • 14.1 Asia-Pacific Summary
  • 14.2 Market Attractive Index
  • 14.3 Asia-Pacific Hybrid Imaging Market, by Technology (2019-2032)
  • 14.4 Asia-Pacific Hybrid Imaging Market, by Type (2019-2032)
  • 14.5 Asia-Pacific Hybrid Imaging Market, by SPECT Market (2019-2032)
  • 14.6 Asia-Pacific Hybrid Imaging Market, by Application (2019-2032)
  • 14.7 Asia-Pacific Hybrid Imaging Market, by End Use (2019-2032)
  • 14.8 Asia-Pacific Hybrid Imaging Market, by Country (2019-2032)
  •   14.8.1 China
  •   14.8.2 India
  •   14.8.3 Japan
  •   14.8.4 South Korea
  •   14.8.5 Singapore
  •   14.8.6 Malaysia
  •   14.8.7 Australia
  •   14.8.8 Thailand
  •   14.8.9 Philippines
  •   14.8.10 Rest of Asia-Pacific

  • SECTION 15 - SOUTH AMERICA HYBRID IMAGING MARKET
  • 15.1 South America Summary
  • 15.2 Market Attractive Index
  • 15.3 South America Hybrid Imaging Market, by Technology (2019-2032)
  • 15.4 South America Hybrid Imaging Market, by Type (2019-2032)
  • 15.5 South America Hybrid Imaging Market, by SPECT Market (2019-2032)
  • 15.6 South America Hybrid Imaging Market, by Application (2019-2032)
  • 15.7 South America Hybrid Imaging Market, by End Use (2019-2032)
  • 15.8 South America Hybrid Imaging Market, by Country (2019-2032)
  •   15.8.1 Brazil
  •   15.8.2 Argentina
  •   15.8.3 Chile
  •   15.8.4 Colombia
  •   15.8.5 Rest of South America

  • SECTION 16 - MIDDLE EAST AND AFRICA HYBRID IMAGING MARKET
  • 16.1 Middle East and Africa Summary
  • 16.2 Market Attractive Index
  • 16.3 Middle East and Africa Hybrid Imaging Market, by Technology (2019-2032)
  • 16.4 Middle East and Africa Hybrid Imaging Market, by Type (2019-2032)
  • 16.5 Middle East and Africa Hybrid Imaging Market, by SPECT Market (2019-2032)
  • 16.6 Middle East and Africa Hybrid Imaging Market, by Application (2019-2032)
  • 16.7 Middle East and Africa Hybrid Imaging Market, by End Use (2019-2032)
  • 16.8 Middle East and Africa Hybrid Imaging Market, by Country (2019-2032)
  •   16.8.1 Kingdom of Saudi Arabia
  •   16.8.2 South Africa
  •   16.8.3 U.A.E.
  •   16.8.4 Egypt
  •   16.8.5 Rest of Middle East and Africa

  • SECTION 17 - COMPANY SHARE ANALYSIS
  • 17.1 Global Hybrid Imaging Market, Company Share Analysis
  • 17.2 North America Hybrid Imaging Market, Company Share Analysis
  • 17.3 Europe Hybrid Imaging Market, Company Share Analysis
  • 17.4 Asia-Pacific Hybrid Imaging Market, Company Share Analysis

  • SECTION 18 - COMPANY PROFILES
  • 18.1 GE HealthCare
  •   18.1.1 Company Snapshot
  •   18.1.2 Financial Overview
  •   18.1.3 Product Portfolio
  •   18.1.4 Recent Developments
  • 18.2 Siemens Healthcare
  •   18.2.1 Company Snapshot
  •   18.2.2 Financial Overview
  •   18.2.3 Product Portfolio
  •   18.2.4 Recent Developments
  • 18.3 Koninklijke Philips N.V.
  •   18.3.1 Company Snapshot
  •   18.3.2 Financial Overview
  •   18.3.3 Product Portfolio
  •   18.3.4 Recent Developments
  • 18.4 CANON MEDICAL SYSTEMS CORPORATION
  •   18.4.1 Company Snapshot
  •   18.4.2 Financial Overview
  •   18.4.3 Product Portfolio
  •   18.4.4 Recent Developments
  • 18.5 Shanghai United Imaging Healthcare Co., LTD
  •   18.5.1 Company Snapshot
  •   18.5.2 Financial Overview
  •   18.5.3 Product Portfolio
  •   18.5.4 Recent Developments
  • 18.6 TTG IMAGING SOLUTIONS (Digirad)
  •   18.6.1 Company Snapshot
  •   18.6.2 Financial Overview
  •   18.6.3 Product Portfolio
  •   18.6.4 Recent Developments
  • 18.7 Carl Zeiss Meditec AG
  •   18.7.1 Company Snapshot
  •   18.7.2 Financial Overview
  •   18.7.3 Product Portfolio
  •   18.7.4 Recent Developments
  • 18.8 Topcon Corporation
  •   18.8.1 Company Snapshot
  •   18.8.2 Financial Overview
  •   18.8.3 Product Portfolio
  •   18.8.4 Recent Developments
  • 18.9 Heidelberg Engineering
  •   18.9.1 Company Snapshot
  •   18.9.2 Financial Overview
  •   18.9.3 Product Portfolio
  •   18.9.4 Recent Developments
  • 18.10 NIDEK
  •   18.10.1 Company Snapshot
  •   18.10.2 Financial Overview
  •   18.10.3 Product Portfolio
  •   18.10.4 Recent Developments

  • SECTION 19 - RELATED REPORTS

  • SECTION 20 - DISCLAIMER

​RESEARCH METHODOLOGY

The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.

Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.

The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.

Below mention are few of the sources which we have considered while estimating the market size:
For instance,
  • Research articles published on Technium
  • Science and MDPI
  • Research publications by government approved associations and societies

Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING

The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.

MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.

Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.

We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT

Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.

Choose License Type

  • $3599
    $4799
    $5899
    $7499